PRA International to host interactive round-table sessions on drug development, lifecycle management

PRA International, a leading Clinical Research Organization (CRO), will host five interactive round-table sessions on drug development and lifecycle management at the Drug Information Association's (DIA) annual meeting in Washington, D.C. 13-17 June 2010.

Drug development and lifecycle management have never been more challenging and the ground is constantly shifting in this area. To discuss solutions to the field's toughest issues and latest developments, conference attendees can join PRA at booth 901 for expert round-table sessions.  These highly interactive forums will review:

• The challenges and benefits of reporting serious adverse events using electronic data capture systems.
• Attributes of high-performing teams between biopharma companies and their CRO partners.
• Risk evaluation and mitigation strategies and post-marketing commitments.
• Using clinical informatics to achieve successful patient recruitment and retention.
• Information lifecycle management — improving access to critical information.

PRA will also exhibit at booth 901, where attendees can learn more about our broad range of services.  Along with representatives from all of PRA's services, leaders of the following PRA business units will be in attendance: Business Development, Clinical Informatics, Clinical Operations (Americas), Corporate Services, IT, Late Phase Services, Patient Recruitment and Retention, Safety & Risk Management Services, and the PRA Infectious Disease Research Center.